Status:
COMPLETED
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
Murdoch Childrens Research Institute
Conditions:
Asthma
Eczema
Eligibility:
All Genders
3-9 years
Brief Summary
The prevalence of asthma and allergic diseases is increasing worldwide. Infections and vaccinations in childhood may have an impact on the subsequent development of asthma and allergy. In Guinea-Bissa...
Detailed Description
Background: Prevalence of asthma and allergy is increasing worldwide, and the cause is unclear. Previous work by the Bandim Health Project and others has identified that infections and routine childho...
Eligibility Criteria
Inclusion
- Previous enrolment in NCT00146302
- Living within Bandim Health Project study area
Exclusion
- Children with known history of anaphylaxis
- Children with skin infections or severe skin conditions for who SPT could not be reliably performed
- Children currently taking anti-histamine medication
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
487 Patients enrolled
Trial Details
Trial ID
NCT01420705
Start Date
October 1 2011
End Date
December 1 2011
Last Update
December 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bandim, Guinea-Bissau